These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813 [TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma: what is the role of molecular genetics? Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461 [TBL] [Abstract][Full Text] [Related]
5. Review of the prognostic factors in medulloblastoma of children and adults. Brandes AA; Paris MK Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661 [TBL] [Abstract][Full Text] [Related]
6. Consensus guidelines for the management of pediatric medulloblastoma in low and middle-income countries. Mushtaq N; Enam SA; Bajwa MH; Mustansir F; Baig E; Gauhar F; Arif A; Khan AA; Hamid SA; Javed G; Mubarak F; Qureshi BM; Minhas K; Kirmani S; Resham S; Bashir A; Yousaf I; Gilani A; Bouffet E; Mughal N; J Pak Med Assoc; 2024 Mar; 74(3 (Supple-3)):S116-S125. PubMed ID: 39262072 [TBL] [Abstract][Full Text] [Related]
7. Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group. Cooney T; Lindsay H; Leary S; Wechsler-Reya R Neoplasia; 2023 Jan; 35():100861. PubMed ID: 36516489 [TBL] [Abstract][Full Text] [Related]
8. EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Franceschi E; Hofer S; Brandes AA; Frappaz D; Kortmann RD; Bromberg J; Dangouloff-Ros V; Boddaert N; Hattingen E; Wiestler B; Clifford SC; Figarella-Branger D; Giangaspero F; Haberler C; Pietsch T; Pajtler KW; Pfister SM; Guzman R; Stummer W; Combs SE; Seidel C; Beier D; McCabe MG; Grotzer M; Laigle-Donadey F; Stücklin ASG; Idbaih A; Preusser M; van den Bent M; Weller M; Hau P Lancet Oncol; 2019 Dec; 20(12):e715-e728. PubMed ID: 31797797 [TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary Management of Medulloblastoma: Consensus, Challenges, and Controversies. Chatterjee A; Maitre M; Dasgupta A; Sridhar E; Gupta T Methods Mol Biol; 2022; 2423():215-235. PubMed ID: 34978701 [TBL] [Abstract][Full Text] [Related]
10. Management and outcomes of treating pediatric medulloblastoma: an eight years' experience in an Iranian pediatric center. Mehrvar A; Tashvighi M; Hedayati Asl AA; Niktoreh-Mofrad N; Mehrvar N; Afsar N; Naderi A; Allebouyeh M; Qaddoumi I; Faranoush M Childs Nerv Syst; 2018 Apr; 34(4):639-647. PubMed ID: 29214340 [TBL] [Abstract][Full Text] [Related]
11. Updates on Management of Adult Medulloblastoma. Majd N; Penas-Prado M Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711 [TBL] [Abstract][Full Text] [Related]
12. Metastatic medulloblastoma at diagnosis. Gupta S; Pant MC; Husain N; Sundar S J Cancer Res Ther; 2011; 7(2):203-4. PubMed ID: 21768715 [TBL] [Abstract][Full Text] [Related]
13. Medulloblastomas in adolescents and adults - Can the pediatric experience be extrapolated? Frappaz D; Faure-Conter C; Bonneville Levard A; Barritault M; Meyronet D; Sunyach MP Neurochirurgie; 2021 Feb; 67(1):76-82. PubMed ID: 30554773 [TBL] [Abstract][Full Text] [Related]